HRTX

Heron Therapeutics, Inc.

2.66 USD
-0.04 (-1.48%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Heron Therapeutics, Inc. stock is up 6.83% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 10 March’s closed higher than February. In the last 9 Unusual Options Trades, there were 9 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
05 Jan 17:19 15 Mar, 2024 2.00 CALL 1206 2017
05 Jan 19:04 15 Mar, 2024 2.00 CALL 5000 2017
08 Jan 14:52 15 Mar, 2024 2.00 CALL 4999 12001
08 Jan 20:45 15 Mar, 2024 2.00 CALL 666 12001
09 Jan 15:26 15 Mar, 2024 2.00 CALL 4984 16560
16 Jan 20:50 19 Jan, 2024 1.50 CALL 500 1117
31 Jan 16:21 15 Mar, 2024 3.00 CALL 2255 1864
15 Feb 15:34 21 Jun, 2024 3.00 CALL 4998 1001
28 Feb 16:05 15 Mar, 2024 1.00 CALL 201 1150

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy.